Clinical inertia: A critique of medical reason

Clinical Inertia: A Critique of Medical Reason

Volumn , Issue , 2015, Pages 1-142

  Reach, Gérard ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84955667473     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-09882-1     Document Type: Book

References (453)

1. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS. Clinical inertia. Ann Intern Med. 2001;135:825–34.
2. Leslie CA, Satin-Rapaport W, Matheson D, Stone R, Enfi eld G. Psychological insulin resistance: a missed diagnosis. Diabetes Spectr. 1994;7:52–7.
3. Wallace TM, Matthews DR. Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude. Q J Med. 2000;93:369–74.
4. Branch WT, Higgins S. Clinical inertia: hard to move it forward. Rev Esp Cardiol. 2010; 63:1399–401.
5. WHO. Adherence to long term therapies, evidence for action. Geneva: World Health Organization Publications; 2003.
6. Scheen AJ. Inertie thérapeutique dans la pratique médicale: causes, conséquences, solutions. Rev Med Liège. 2010;65:232–38.
7. Pears D. Motivated irrationality. South Bend: St Augustine’s Press; 1998. p. 1.
8. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud P-A C, Rubin HR. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–67.
9. Cook CB, Ziemer DC, El-Kebbi IM, Gallina DL, Dunbar VG, Ernst KL, Phillips LS. Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes. Diabetes Care. 1999;22:1494–500.
10. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS. Clinical inertia. Ann Intern Med. 2001;135:825–34.
11. Andrade SE, Gurwitz JH, Field TS, Kelleher M, Majumdar SR, Reed G, Black R. Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care. 2004;10:481–6.
12. Okonofua EC, Simpson KN, Jesri A, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the healthy people 2010 blood pressure control goals. Hypertension. 2006;47:345–51.
13. Allen JD, Curtiss FR, Fairman KA. Nonadherence, clinical inertia, or therapeutic inertia? J Manag Care Pharm. 2009;15:690–5.
14. O’Connor PJ, Sperl-Hillen JM, Johnson PE, Rush WA. Identifi cation, classifi cation, and frequency of medical errors in outpatient diabetes care. In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in patient safety: from research to implementation, vol 2: Concepts and methodology. Rockville: Agency for Healthcare Research and Quality (US); 2005.
15. Reach G. The mental mechanisms of patient adherence to long term therapies, mind and care, foreword by Pascal Engel, “Philosophy and Medicine” series, Springer, forthcoming.
16. Field MJ, Lohr KN, editors. Clinical practice guidelines: directions for a new program, insti tute of medicine. Washington, DC: National Academy Press; 1990.
17. HAS. Méthodes d’élaborations des recommandations de bonne pratique. http://www.hassante.fr/portail/jcms/c_5233. Accessed 7 Apr 2014.
18. Evidence Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA. 1992;268:2420–5.
19. Cochrane AL. Effectiveness and effi ciency: random refl ections on health services. London: Nuffield Provincial Hospitals Trust; 1972 (réédition 1989, Royal Society of Medicine Press, London).
20. Cochrane AL. 1931–1971: a critical review, with particular reference to the medical profession. In: Medicines for the year 2000. London: Offi ce of Health Economics; 1979. p. 1–11.
21. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ. 1996;312:71–2.
22. Sir Osler W. The art, aphorism 265. Aphorisms from his bedside teachings and writings. Epitomes collected by Robert Bennett Bean, Charles C. Thomas, Springfi eld Ill, 1961.
23. Evidence-Practice Gaps. Complete report, vol 1. http://www.nhmrc.gov.au/_fi lesnhmrc/file/nics/material_resources/Evidence_volumeonecolour.pdf. Accessed 7 Apr 2014.
24. Liang L. The gap between evidence and practice. Health Aff. 2007;26:w119–21.
25. Kosecoff J, Kanouse DE, Rogers WH, McClosey L, Winslow CM, Brook RH. Effects of the national institutes of health consensus development program on physician practice. JAMA. 1987;258:2708–13.
26. Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med. 1989;321:1306–11.
27. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, Kerr EA. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348:2635–45.
28. Karve A, Hayward RA. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults. Diabetes Care. 2010;33:2355–9.
29. Toussi M, Ebrahiminia V, Le Toumelin P, Cohen R, Venot A. An automated method for analyzing adherence to therapy guidelines: application in diabetes. In: Andersen SK et al., editors. E-Health beyond the horizon –get IT there. Amsterdam/Oxford: IOS Press; 2008. p. 339–44.
30. Davis DA, Taylor-Vaisey A. Translating guidelines into practice, a systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. Can Med Assoc J. 1997;157:408–16.
31. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, Whitty P, Eccles MP, Matowe L, Shirran L, Wensing M, Dijkstra R, Donaldson C. Effectiveness and effi ciency of guideline dissemination and implementation strategies. Executive summary. Health Technol Assess. 2004;8(6):iii–iv, 1–72.
32. Kohn LT, Corrigan JM, Donaldson MS. To err is human: building a safer health system, free executive summary. National Academy Press; 2000. http://www.nap.edu/catalog/9728.html. Accessed 7 Apr 2014.
33. Dovey SM, Meyers DS, Phillips Jr RL, Green LA, Fryer GE, Galliher JM, Kappus J, Grob P. A preliminary taxonomy of medical errors in family practice. Qual Saf Health Care. 2002;11:233–8.
34. Kennedy AG, MacLean CD. Clinical inertia: errors of omission in drug therapy. Am J Health Syst Pharm. 2004;61:401–4.
35. O’Connor PJ, Sperl-Hillen JAM, Johnson PE, Rush WA, Biltz G. Clinical inertia and outpatient medical errors. In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in patient safety: from research to implementation, vol 2: Concepts and methodology. Rockville: Agency for Healthcare Research and Quality (US); 2005.
36. Kerr EA, Krein SR, Vijan S, Hofer TP, Hayward RA. Avoiding pitfalls in chronic disease quality measurement: a case for the next generation of technical quality measures. Am J Manag Care. 2001;7:1033–43.
37. Kerr EA, Smith DM, Hogan MM, Hofer TP, Krein SR, Bermann M, Hayward RA. Building a better quality measure. Are some patients with “poor quality” actually getting good care? Med Care. 2003;41:1173–82.
38. Hicks PC, Westfall JM, Van Vorst RF, Bublitz Emsermann C, Dickinson LM, Pace W, Parnes B. Action or inaction? Decision making in patients with diabetes and elevated blood pressure in primary care. Diabetes Care. 2006;29:2580–5.
39. Safford MM, Shewchuk R, Qu H, Williams JH, Estrada CA, Ovalle F, Allison JJ. Reasons for not intensifying medications: differentiating “clinical inertia” from appropriate care. J Gen Intern Med. 2007;22:1648–55.
40. Persell SD, Dolan NC, Friesema EM, Thompson JA, Kaiser D, Baker DW. Frequency of inappropriate medical exceptions to quality measures. Ann Intern Med. 2010;152:225–31.
41. Reach G. Inertie clinique: comment est-elle possible? Médecine des Maladies Métaboliques. 2011;5:567–73.
42. Rodondi N, Peng T, Karter AJ, Bauer DC, Vittinghoff E, Tang S, Pettitt D, Kerr EA, Selby JV. Therapy modifi cations in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med. 2006;144:475–84.
43. Berlowitz DR, Ash AS, Hickey E, Friedman RRH, Glickman M, Kader B, Moskowitz MA. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957–63.
44. Okonofua EC, Simpson KN, Jesri A, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the healthy people 2010 blood pressure control goals. Hypertension. 2006;47:345–51.
45. Balkau B, Bouée S, Avignon A, Vergès B, Chartier I, Amelineau E, Halimi S. Type 2 diabetes treatment intensifi cation in general practice in France in 2008–2009: The DIAttitude study. Diabetes Metab. 2012;38 Suppl 3:S29–35.
46. Simon D. Therapeutic inertia in type 2 diabetes: insights from the PANORAMA study in France. Diabetes Metab. 2012;38 Suppl 3:S47–52.
47. Berlowitz DR, Ash AS, Glickman M, Friedman RH, Pogach LM, Nelson AL, Wong AT. Developing a quality measure for clinical inertia in diabetes care. Health Res Educ Trust. 2005;40:1836–51.
48. Lazaro P, Murga N, Aguilar D, Hernandez-Presa MA. Therapeutic Inertia in the outpatient management of dyslipidemia in patients with ischemic heart disease. The inertia study. Rev Esp Cardiol. 2010;63:1428–37.
49. Kerr EA, Smith DM, Hogan MM, Hofer TP, Krein SR, Bermann M, Hayward RA. Building a better quality measure. Are some patients with “poor quality” actually getting good care ? Med Care. 2003;41:1173–82.
50. Gil-Guillén V, Orozco-Beltrán D, Carratalá-Munuera C, Márquez-Contreras E, Durazo- Arvizu R, Cooper R, Pertusa-Martínez S, Pita-Fernandez S, González-Segura D, Martin-de- Pablo JL, Pallarés V, Fernández A, Redón J. Clinical inertia in poorly controlled elderly hypertensive patients: a cross-sectional study in spanish physicians to ascertain reasons for not intensifying treatment. Am J Cardiovasc Drugs. 2013;13:213–9.
51. Nelson SAE, Dresser GK, Vandervoort MK, Wong CJ, Feagan BG, Mahon JL, Feldman RD. Barriers to blood pressure control: a STITCH substudy. J Clin Hypertens (Greenwich). 2011;13:73–80.
52. Green BB, Cook AJ, Ralston JD, et al. Effectiveness of home blood pressure monitoring, web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299:2857–67.
53. Simpson SH, Majumdar SR, Tsuyuki RT, et al. Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care. 2011;34:20–6.
54. Rinfret S, Lussier MT, Peirce A, et al. The impact of a multidisciplinary information technologysupported program on blood pressure control in primary care. Circ Cardiovasc Qual Outcomes. 2009;2:170–7.
55. Luders S, Schrader J, Schmieder RE, Smolka W, Wegscheider K, Bestehorn K. Improvement o hypertension management by structured physician education and feedback system: cluster randomized trial. Eur J Cardiovasc Prev Rehabil. 2010;17:271–9.
56. Huebschmann AG, Mizrahi T, Soenksen A, Beaty BL, Denberg TD. Reducing clinical inertia in hypertension treatment: a pragmatic randomized controlled trial. J Clin Hypertens (Greenwich). 2012;14:322–9.
57. Crowley MJ, Smith VA, Olsen MK, Danus S, Oddone EZ, Bosworth HB, Powers BJ. Treatment intensifi cation in a hypertension telemangement trial. Clinical inertia or good clinical judgment ? Hypertension. 2011;58:552–8.
58. Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care. 2004;27:1535–40.
59. McEwen LN, Johnson SL, Halter JB, Karter AJ, Mangione CM, Subramanian U, Waitzfelder B, Crosson JC, Herman WH. Predictors and impact of intensifi cation of antihyperglycemic therapy in type 2 diabetes. Translating Research into Action for Diabetes (TRIAD). Diabetes Care. 2009;32:971–6.
60. Samuels TA, Bolen S, Yeh HC, Abuid M, Marinopoulos SS, Weiner JP, McGuire M, Brancati FL. Missed opportunities in diabetes management: a longitudinal assessment of factors associated with sub-optimal quality. J Gen Intern Med. 2008;23:1770–7.
61. Selby JV, Uratzu CS, Fireman B, Schmittdiel JA, Peng T, Rodondi N, Karter A, Kerr EA. Treatment intensifi cation and risk factor control: Toward more clinically relevant quality measures. Med Care. 2009;47:395–402.
62. Schmittdiel JA, Uratsu CS, Karter AJ, Heisler M, Subramanian U, Mangione CM, Selby JV. Why don’t diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensifi cation. J Gen Intern Med. 2008;23:588–94.
63. Touzé E, Coste J, Voicu M, Kansao J, Masmoudi R, Doumenc B, Durieux P, Mas JL. Importance of in-hospital initiation of therapies and therapeutic inertia in secondary stroke prevention. Implementation of Prevention After a Cerebrovascular evenT (IMPACT) study. Stroke. 2008;39:1834–43.
64. Cook CB, Ziemer DC, El-Kebbi IM, Gallina DL, Dunbar VG, Ernst KL, Phillips LS. Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes. Diabetes Care. 1999;22:1494–500.
65. El-Kebbi IM, Ziemer DC, Musey VC, Gallina DL, Bernard AM, Phillips LS. Diabetes in urban African-Americans. IX Provider adherence to management protocols. Diabetes Care. 1997;20:698–703.
66. El-Kebbi IM, Ziemer DC, Gallina DL, Dunbar V, Phillips LS. Diabetes in urban African- Americans. XV Identifi cation of barriers to provider adherence to management protocols. Diabetes Care. 1999;22:1617–20.
67. Brown JB, Nichols GA. Slow response to loss of glycemic control in type 2 diabetes mellitus. Am J Manag Care. 2003;9:213–7.
68. Shah BJ, Hux JE, Laupacis A, Zinman B, van Walraven C. Clinical inertia in response to inadequate glycemic control. Do specialists differ from primary care physicians? Diabetes Care. 2005;28:600–6.
69. Ziemer DC, Miller CD, Rhee MK, Doyle JP, Watkins Jr C, Cook CB, Gallina DL, El-Kebbi IM, Barnes CS, Dunbar VG, Branch Jr WT, Phillips LS. Clinical inertia contributes to poor diabetes control in a primary care setting. Diabetes Educ. 2005;31:564–71.
70. Grant RW, Caglero E, Dubey AK, Gildesgame C, Chueh HC, Barry MJ, Singer DE, Nathan DM, Meigs JB. Clinical inertia in the management of type 2 diabetes metabolic risk factors. Diabet Med. 2004;21:150–5.
71. Grant RW, Buse JB, Meigs JB. Quality of diabetes care in U.S. academic medical centers. Diabetes Care. 2005;28:337–442.
72. Wee SL, Tan CG, Ng HS, Su C, Tai VU, Flores JVPG, Kho DHC. Diabetes outcome in specialist and general practitioner settings in Singapore: challenges of right-siting. Ann Acad Med Singapore. 2008;37:929–35.
73. Van Bruggen R, Gorter K, Stolk R, Klungel O, Rutten G. Clinical inertia in general practice: widespread and related to the outcome of diabetes care. Fam Pract. 2009;26:428–36.
74. Bolen SD, Bricker E, Samuels TA, Yeh HC, Marinopoulos SS, McGuire M, Abuid M, Brancati FL. Factors associated with intensifi cation of oral diabetes medications in primary care provider-patient dyads: a cohort study. Diabetes Care. 2009;32:25–31.
75. Knecht LA, Gauthier SM, Castro JC, Schmidt RE, Whitaker MD, Zimmerman RS, Mishark KJ, Cook CB. Diabetes care in the hospital: is there clinical inertia? J Hosp Med. 2006;1:151–60.
76. Cook CB, Castro JC, Schmidt RE, Whitaker MD, Roust LR, Argueta R, Hull BP, Zimmerman RS. Diabetes care in hospitalized non critically ill patients: more evidence for clinical inertia and negative therapeutic momentum. J Hosp Med. 2007;2:203–11.
77. Cook CB, Zimmerman RS, Gauthier SM, Castro JC, Jameson KA, Littman SD, Magallanez JM. Understanding and improving management of inpatient diabetes mellitus: the Mayo Clinic Arizona experience. J Diabetes Sci Technol. 2008;2:925–31.
78. Griffi th ML, Boord JB, Eden SK, Matheny ME. Clinical inertia of discharge planning among patients with poorly controlled diabetes mellitus. J Clin Endocrinol Metab. 2012;97:2019–26.
79. Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, Landgraf R, Kleinebreil L, International DAWN Advisory Panel. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care. 2005;28:2673–9.
80. Harris SB, Kapor J, Lank CN, Willan AR, Houston T. Clinical inertia in patients with T2DM requiring insulin in family practice. Can Fam Physician. 2010;56:e418–24.
81. Leslie CA, Satin-Rapaport W, Matheson D, Stone R, Enfi eld G. Psychological insulin resistance: a missed diagnosis. Diab Spectr. 1994;7:52–7.
82. Phillips P. Type 2 diabetes – failure, blame and guilt in the adoption of insulin therapy. Rev Diab Stud. 2005;2:35–9.
83. Peyrot M, Rubin RR, Khunti K. Addressing barriers to initiation of insulin in patients with type 2 diabetes. Prim Care Diabetes. 2010;4 Suppl 1:11–8.
84. Woudenberg YJ, Lucas C, Latour C, Scholte O, Reimer WJ. Acceptance of insulin therapy: a long shot? Psychological insulin resistance in primary care. Diabet Med. 2012;29:796–802.
85. Hayes RP, Fitzgerald JT, Jacober SJ. Primary care physician beliefs about insulin initiation in patients with type 2 diabetes. Int J Clin Pract. 2008;62:860–8.
86. Ndong JR, Romon I, Druet C, Prévot L, Hubert-Brierre R, Pascolini E, Thomaset JP, Cheungkin R, Bravo A, Chantry M, Deligne J, Paumier A, Weill A, Fagot-Campana A. Caractéristiques, risque vasculaire, complications et qualité des soins des personnes diabétiques dans les départements d’outre-mer et comparaison à la métropole: Entred 2007–2010, France. BEH. 2010;42–43:432–6.
87. Alexander M, Tekawa I, Hunkeler E, Fireman B, Rowell R, Selby JV, Massie BM, Cooper W. Evaluating hypertension control in a managed care setting. Arch Intern Med. 1999;159:2673–7.
88. Knight EL, Bohn RL, Wang PS, Glynn RJ, Mogun H, Avorn J. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension. 2001;38:809–14.
89. Oliveria SA, Lapuerta P, McCarthy BD, L’Italien GJ, Berlowitz DR, Ash SM. Physicianrelated barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413–20.
90. Andrade SE, Gurwitz JH, Field TS, Kelleher M, Majumdar SR, Reed G, Black R. Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care. 2004;10:481–6.
91. Gil-Guillén V, Orozco-Beltran D, Pérez RP, Alfonso JL, Redon J, Pertusa-Martinez S, Navarro J, Cea-Calvo L, Quirce-Andres F, Merino-Sanchez J, Carratala C, Martin-Moreno JM. Clinical inertia in diagnosis and treatment of hypertension in primary care: quantification and association factors. Blood Press. 2010;19:3–10.
92. Bolen SD, Samuels TA, Yeh HC, Marnopoulos SS, McGuire M, Abuid M, Brancati FL. Failure to intensify antihypertensive treatmenet by primary care providers: a cohort study in adults with diabetes mellitus and hypertension. J Gen Intern Med. 2008;23:543–50.
93. Viera AJ, Schmid D, Bostrom S, Yow A, Lawrence W, DuBard CA. Level of blood pressure above goal and clinical inertia in a medicaid population. J Am Soc Hypertens. 2010;4:244–54.
94. Spranger CB, Ries A, Berge CA, Radford NB, Victor RG. Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension. Am J Med. 2004;117:14–8.
95. Lin ND, Martins SB, Chan AS, Coleman RW, Bosworth HB, Oddone EZ, Shankar RD, Musen MA, Hoffman BB, Goldstein MK. Identifying barriers to hypertension guideline adherence using clinician feedback at the point of care. AMIA 2006 symposium proceedings. AMIA Symposium, American Medical Informatics Association. 2006. p. 494–8.
96. Bramlage P, Thoenes M, Kirch W, Lenfant C. Clinical practice and recent recommendations in hypertension management–reporting a gap in a global survey of 1259 primary care physicians in 17 countries. Curr Med Res Opin. 2007;23:783–91.
97. Holland N, Segraves D, Nnadi VO, Belletti DA, Wogen J, Arcona S. Identifying barriers to hypertension care: implications for quality improvement initiatives. Dis Manag. 2008;11:71–7.
98. Ferrari P. Reasons for therapeutic inertia when managing hypertension in clinical practice in non-western countries. J Hum Hypertens. 2009;23:151–9.
99. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS. Clinical inertia. Ann Intern Med. 2001;135:825–34.
100. McBride P, Schrott HG, Plane MB, Underbakke G, Brown RL. Primary care adherence to national cholesterol education program guidelines for patients with coronary heart disease. Arch Intern Med. 1998;158:1238–44.
101. Pearson T, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipidlowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med. 2000;160:459–67.
102. Goldberg KC, Melnyk SD, Simel DL. Overcoming inertia: improvement in achieving target low-density lipoprotein cholesterol. Am J Manag Care. 2007;13:530–4.
103. Willig JH, Jacson DA, Westfall AO, Allison J, Chang PW, Raper J, Saag MS, Mugavero MJ. Clinical inertia in the management of low-density lipoprotein abnormalities in an HIV clinic. Clin Infect Dis. 2008;46:1315–8.
104. Abuful A, Gidron Y, Henkin Y. Physicians’ attitudes toward preventive therapy for coronary artery disease: is there a gender bias? Clin Cardiol. 2005;28:389–93.
105. Kim C, Hofer T, Kerr EA. Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women. A conceptual model. J Gen Intern Med. 2003;18:854–63.
106. Heeley EL, Peiris DP, Patel AA, Cass A, Weekes A, Morgan C, Anderson CS, Chalmers JP. Cardiovascular risk perception and evidence-practice gaps in Australian general practice (the AusHEART study). Med J Aust. 2010;192:254–9.
107. Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, Fabunmi RP, Kwan J, Mills T, Simpson SL. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111:499–510.
108. Cleland JGF, Swedberg K, Follath F, Komadja M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Predam I, van Gilst WH, Widimsk J, Freemantle N, Eastaugh J, Mason J. The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe part 1: patient characteristics and diagnosis. Eur Heart J. 2003;24:442–63.
109. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, Van Gilst WH, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Widimsky J, Freemantle N, Eastaugh J, Mason J. The EuroHeart failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J. 2003;24:464–74.
110. Cleland JGF, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, Freemantle N, Gavazzi A, van Gilst WH. Management of heart failure in primary care (the IMPROVEMENT of heart failure programme): an international survey. Lancet. 2002;360:1631–9.
111. Komajda M, Lapuerta P, Hermans N, Gonzalez-Juanatey JR, van Veldhuisen DJ, Erdmann E, Tavazzi L, Poole-Wilson P, Le Pen C. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J. 2005;26:1653–9.
112. Braun E, Landsman K, Zuckerman R, Berger G, Meilik A, Azzam ZS. Adherence to guidelines improves the clinical outcome of patients with acutely decompensated heart failure. IMAJ. 2009;11:348–53.
113. Iung B, Messika-Zeitoun D, Cachier A, Delahaye F, Baron G, Tornos P, Gohlke-Bärwolf C, Boersma E, Ravaud P, Vahanian A. Actual management of patients with asymptomatic aortic valve disease: how practice fi ts with guidelines. Am Heart J. 2007;153:696–703.
114. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, Gohlke-Bärwolf C, Boersma E, Ravaud P, Vahanian A. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26:2714–20.
115. Detaint D, Iung B, Lepage L, Messika-Zeitoun D, Baron G, Tornos P, Gohlke-Bärwolf C, Vahanian A. Management of asymptomatic patients with severe non-ischaemic mitral regurgitation. Are practices consistent with guidelines? Eur J Cardiothorac Surg. 2008;34:937–42.
116. Nieuwlaat R, Capucci A, Lip GY, Olsson SB, Prins MH, Nieman FH, Lopez-Sendon J, Vardas PE, Aliot E, Santini M, Crijns HJ. Antithrombotic treatment in real-life atrial fi brillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J. 2006;27:3018–26.
117. Nieuwlaat R, Olsson SB, Lip GY, Camm AJ, Breithardt G, Capucci A, Meeder JG, Prins MH, Lévy S, Crijns HJ. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fi brillation. The Euro Heart Survey on Atrial Fibrillation. Am Heart J. 2007;153:1006–12.
118. Gattellari M, Worthington J, Zwar N, Middleton S. Barriers to the use of anticoagulation for nonvalvular atrial fi brillation: a representative survey of Australian family physicians. Stroke. 2008;39:227–30.
119. Choudhry NK, Anderson GM, Laupacis A, Ross-Degnan D, Normand SLT, Soumerai SB. Impact of adverse events on prescribing warfarin in patients with atrial fi brillation: matched pair analysis. BMJ. doi: 10.1136/bmj.38698.709572.55.
120. Crim C. Clinical practice guidelines vs actual clinical practice. The asthma paradigm. Chest. 2000;118:62S–4.
121. Cabana MD, Ebel BE, Cooper-Patrick L, Powe NR, Rubin HR, Rand CS. Barriers pediatricians face when using asthma guidelines. Arch Pediatr Adolesc Med. 2000;154:683–93.
122. Wiener-Ogielvie S, Pinnock H, Huby G, Sheikh A, Partridge MR, Gillies J. Do practices comply with key recommendations of the British Asthma Guideline? If not, why not ? Prim Care Respir J. 2007;116:369–77.
123. Gildenhuys J, Lee M, Isbister GK. Does implementation of a paediatric asthma clinical practice guideline worksheet change clinical practice? Int J Emerg Med. 2009;2:33–9.
124. Cabana MD, Flores G. The role of clinical practice guidelines in enhancing quality and reducing racial/ethnic disparities in paediatrics. Paediatr Respir Rev. 2002;3:52–8.
125. Byrnes P, McGoldrick C, Crawford M. Asthma cycle of care attendance. Overcoming therapeutic inertia using an asthma clinic. Aust Fam Physician. 2010;39:318–20.
126. Price D, Thomas M. Breaking new ground: challenging existing asthma guidelines. BMC Pulm Med. 2006;6 Suppl 1:S6. doi: 10.1186/1471-2466-6-S1-S6.
127. Rabenda V, Reginster JY. Prévention et traitement de l’ostéoporose: éviter l’inertie clinique et motiver l’adhésion au traitement. Rev Med Liege. 2010;65:358–65.
128. Rabenda V, Vanoverloop J, Fanbri V, Mertens R, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY. Low incidence of anti-osteoporosis treatment after hip fracture. J Bone Joint Surg Am. 2008;90:2142–8.
129. Roerholt C, Eiken P, Abrahamsen B. Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence. Osteoporos Int. 2009;20:299–307.
130. Feldstein AC, Nichols GA, Elmer PJ, Smith DH, Aickin M, Herson M. Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. J Bone Joint Surg Am. 2003;85-A:2294–302.
131. Cheng N, Green ME. Osteoporosis screening for men. Are family physicians following the guidelines? Can Fam Physician. 2008;54:1140–1.e1–5.
132. Guzman-Clark JR, Fang MA, Sehl ME, Traylor L, Hahn TJ. Barriers in the management of glucocorticoid-induced osteoporosis. Arthritis Rheum. 2007;57:140–6.
133. Feldstein AC, Elmer PJ, Nichols GA, Herson M. Practice patterns in patients at risk for glucocorticoid- induced osteoporosis. Osteoporos Int. 2005;16:2168–74.
134. Chenot R, Scheidt-Nave C, Gabler S, Kochen MM, Himmel W. German primary care doctors’ awareness of osteoporosis and knowledge of national guidelines. Exp Clin Endocrinol Diabetes. 2007;115:584–9.
135. Henke RM, Zaslavsky AM, McGuire TG, Ayanian JZ, Rubenstein LV. Clinical inertia in depression treatment. Med Care. 2009;47:959–67.
136. Guerra CE, Schwartz JS, Armstrong K, Brown JS, Halbert CH, Shea JA. Barriers of and facilitators to physician recommendation of colorectal cancer screening. J Gen Intern Med. 2007;22:1681–8.
137. Cavazos JM, Naik AD, Woofter A, Abraham S. Barriers to physician adherence to nonsteroidal anti-infl ammatory drug guidelines: a qualitative study. Aliment Pharmacol Ther. 2008;28:789–98.
138. Defl andre E, Degey S, Clerdain AM, Jaucot J, Joris J, Brichant JF. Sevrage tabagique en préopératoire: une période propice pour lutter contre l’inertie et le défaut d’observance. Rev Med Liege. 2010;65:332–7.
139. Pintiaux A, Bouuaert C, Habay N, Beliard A, Foidart JM, Nisolle M. L’inertie thérapeutique en contraception. Rev Med Liege. 2010;65:2391–4.
140. Masson V, Petit P, Foidart JM. Défaut d’observance et inertie thérapeutique en obstétrique. Rev Med Liege. 2010;65:395–8.
141. Scheen AJ, Giet D. Editorial. Cibler l’inertie et le défaut d’observance thérapeutiques: nouveau défi pour améliorer les performances de la pratique médicale. Rev Med Liege. 2010;65:229–31.
142. Reach G. Éditorial, Inertie clinique: ce que révèle le concept. Médecine Mal Métaboliques. 2011;5 Suppl 2:S43–5.
143. Reach G. The mental mechanisms of patient adherence to long term therapies, mind and care, foreword by Pascal Engel, “Philosophy and Medicine” series, Springer, forthcoming.
144. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS. Clinical inertia. Ann Intern Med. 2001;135:825–34.
145. Bolen SD, Samuels TA, Yeh HC, Marnopoulos SS, McGuire M, Abuid M, Brancati FL. Failure to intensify antihypertensive treatment by primary care providers: a cohort study in adults with diabetes mellitus and hypertension. J Gen Intern Med. 2008;23:543–50.
146. Willig JH, Jacson DA, Westfall AO, Allison J, Chang PW, Raper J, Saag MS, Mugavero MJ. Clinical inertia in the management of low-density lipoprotein abnormalities in an HIV clinic. Clin Infect Dis. 2008;46:1315–8.
147. Bolen SD, Bricker E, Samuels TA, Yeh HC, Marinopoulos SS, McGuire M, Abuid M, Brancati FL. Factors associated with intensifi cation of oral diabetes medications in primary care provider-patient dyads: a cohort study. Diabetes Care. 2009;32:25–31.
148. Viera AJ, Schmid D, Bostrom S, Yow A, Lawrence W, DuBard CA. Level of blood pressure above goal and clinical inertia in a Medicaid population. J Am Soc Hypertens. 2010;4:244–54.
149. Turner BJ, Hollenbeak CS, Weiner M, Ten Have T, Tang SS. Effect of unrelated comorbid conditions on hypertension management. Ann Intern Med. 2008;148:578–86.
150. Parchman ML, Pugh JA, Romero RL, Bowers KW. Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. Ann Fam Med. 2007;5:196–201.
151. Suraci C, Mulas F, Rossi MC, Gentile S, Giorda CB. Management of newly diagnosed patients with type 2 diabetes: what are the attitudes of physicians? A SUBITO!AMD survey on the early diabetes treatment in Italy. Acta Diabetol. 2012;49:429–33.
152. Phillips LS, Twombly JG. It’s time to overcome clinical inertia. Ann Intern Med. 2008;148:783–5.
153. Andrade SE, Gurwitz JH, Field TS, Kelleher M, Majumdar SR, Reed G, Black R. Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care. 2004;10:481–6.
154. Gil-Guillén V, Orozco-Beltran D, Pérez RP, Alfonso JL, Redon J, Pertusa-Martinez S, Navarro J, Cea-Calvo L, Quirce-Andres F, Merino-Sanchez J, Carratala C, Martin-Moreno JM. Clinical inertia in diagnosis and treatment of hypertension in primary care: quantifi cation and association factors. Blood Press. 2010;19:3–10.
155. Kerr EA, Zikmund-Fisher BJ, Klamerus ML, Subramanian U, Hogan MM, Hofer TP. The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure. Ann Intern Med. 2008;148:717–27.
156. Redón J, Coca A, Lázaro P, Aguilar MD, Cabañas M, Gil N, Sánchez-Zamorano MA, Aranda P. Factors associated with therapeutic inertia in hypertension: validation of a predictive model. J Hypertens. 2010;28:1770–7.
157. El-Kebbi IM, Ziemer DC, Musey VC, Gallina DL, Bernard AM, Phillips LS. Diabetes in urban African-Americans. IX Provider adherence to management protocols. Diabetes Care. 1997;20:698–703.
158. Rose AJ, Shimada SL, Rothendler JA, Reisman JI, Glassman PA, Berlowitz DR, Kressin NR. The accuracy of clinician perceptions of “usual” blood pressure control. J Gen Intern Med. 2008;23:180–3.
159. Banegas JR, Vegazo O, Serrano P, Luengo E, Mantilla T, Fernández R, Civeira F, HISPALIPID Study Group Investigators. The gap between dyslipidemia control perceived by physicians and objective control patterns in Spain. Atherosclerosis. 2006;188:420–4.
160. Sammer CE, Lykens K, Singh KP. Physician characteristics and the reported effect of evidencebased practice guidelines. Health Serv Res. 2008;43:569–81.
161. Flores G. Technical report–racial and ethnic disparities in the health and health care of children. Pediatrics. 2010;125:e979–1020.
162. Cabana MD, Flores G. The role of clinical practice guidelines in enhancing quality and reducing racial/ethnic disparities in paediatrics. Paediatr Respir Rev. 2002;3:52–8.
163. Verma A, Birger R, Bhatt H, Murray J, Millett C, Saxena S, Banarsee R, Gnani S, Majeed A. Ethnic disparities in diabetes management: a 10-year population-based repeated crosssectional study in UK primary care. J Public Health (Oxf). 2010;32:250–8.
164. McLean G, Guthrie B, Sutton M. Differences in the quality of primary medical care for CVD and diabetes across the NHS: evidence from the quality and outcomes framework. BMC Health Serv Res. 2007;7:74.
165. Tseng CW, Tierney EF, Gerzoff RB, Dudley RA, Waitzfelder B, Ackermann RT, Karter AJ, Piette J, Crosson JC, Ngo-Metzger Q, Chung R, Mangione CM. Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research into Action for Diabetes study. Diabetes Care. 2008;31:261–6.
166. Brown AF, Gregg EW, Stevens MR, Karter AJ, Weinberger M, Safford MM, Gary TL, Caputo DA, Waitzfelder B, Kim C, Beckles GL. Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care. 2005;28:2864–70.
167. Jotkowitz AB, Rabinowitz G, Raskin Segal A, Weitzman R, Epstein L, Porath A. Do patients with diabetes and low socioeconomic status receive less care and have worse outcomes? A national study. Am J Med. 2006;119:665–9.
168. Duru OK, Bilik D, McEwen LN, Brown AF, Karter AJ, Curb JD, Marrero DG, Lu SE, Rodriguez M, Mangione CM. Primary language, income and the intensifi cation of anti-glycemic medications in managed care: the (TRIAD) study. J Gen Intern Med. 2011;26:505–11.
169. Faria C, Wenzel M, Lee KW, Coderre K, Nichols J, Belletti DA. A narrative review of clinical inertia: focus on hypertension. J Am Soc Hypertens. 2009;3:267–76.
170. Triplitt C. Improving treatment success rates for type 2 diabetes: recommendations for a changing environment. Am J Manag Care. 2010;16:S195–200.
171. O’Connor PJ, Sperl-Hillen JAM, Johnson PE, Rush WA, Biltz G. Clinical inertia and outpatient medical errors. In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in patient safety: from research to implementation, vol 2: Concepts and methodology. Rockville: Agency for Healthcare Research and Quality (US), 2005.
172. Brown JB, Harris SB, Webster-Bogaert S, Wetmore S, Faulds C, Stewart M. The role of patient, physician and systemic factors in the management of type 2 diabetes mellitus. Fam Pract. 2002;19:344–9.
173. Howes F, Hansen E, Williams D, Nelson M. Barriers to diagnosing and managing hypertension – a qualitative study in Australian general practice. Aust Fam Physician. 2010;39:511–6.
174. Reach G. Patient nonadherence and healthcare-provider inertia are clinical myopia. Diabetes Metab. 2008;34:382–5.
175. Grant R, Adams AS, Trinacty CM, Zhang F, Kleinman K, Soumerai SB, Meigs JB, Ross- Degnan D. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care. 2007;30:807–12.
176. Heisler M, Hogan MM, Hofer TP, Schmittdiel JA, Pladevall M, Kerr EA. When more is not better: treatment intensifi cation among hypertensive patients with poor medication adherence. Circulation. 2008;117:2884–92.
177. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud P-AC, Rubin HR. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–67.
178. Woolf SH. Practice guidelines: a new reality in medicine, III: impact on patient care. Arch Intern Med. 1993;153:2646–55.
179. Cabana MD, Ebel BE, Cooper-Patrick L, Powe NR, Rubin HR, Rand CS. Barriers pediatricians face when using asthma guidelines. Arch Pediatr Adolesce Med. 2000;154:683–93.
180. Main DS, Cohen SJ, DiClemente CC. Measuring physician readiness to change cancer screening: preliminary results. Am J Prev Med. 1995;11:54–8.
181. Pathman DE, Konrad TR, Freed GL, Freeman VA, Koch GG. The awareness-to-adherence model of the steps to clinical guideline compliance: the case of pediatric vaccine recommendations. Med Care. 1996;34:873–89.
182. Mickan S, Burls A, Glasziou P. Patterns of 'leakage' in the utilisation of clinical guidelines: a systematic review. Postgrad Med J. 2011;87:670–9.
183. Kim C, Hofer T, Kerr EA. Review of evidence and explanations for suboptimal screening and treatment of dyslipiemia in women. A conceptual model. J Gen Intern Med. 2003;18:854–63.
184. Maue SK, Segal R, Kimberlin CL, Lipowski EE. Predicting physician guideline compliance: an assessment of motivators and perceived barriers. Am J Manag Care. 2004;10:383–91.
185. Higgins ET. Beyond pleasure and pain. Am Psychol. 1997;52:1280–300.
186. Veazie PJ, Qian F. A role for regulatory focus in explaining and combating clinical inertia. J Eval Clin Pract. 2011;17:1147–52.
187. Trope Y, Liberman N. Temporal construal. Psychol Rev. 2003;110:403–21.
188. Reach G. Obstacles to patient education in chronic diseases: a trans-theoretical analysis. Patient Educ Couns. 2009;77:192–6.
189. Goodman KW. Ethics and Evidence-Based Medicine. Cambridge: Cambridge University Press; 2003. p. 5–6.
190. Cochrane AL. 1931–1971: a critical review, with particular reference to the medical profession. In: Medicines for the year 2000. London: Offi ce of Health Economics; 1979. p. 1–11.
191. Evidence Based Medicine Working Group. Evidence-Based Medicine. A new approach to teaching the practice of medicine. JAMA. 1992;268:2420–5.
192. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ. 1996;312:71–2.
193. Delvenne C, Pasleau F. Comment résoudre en pratique un problème diagnostique ou thérapeutique en suivant une démarche EBM? Rev Med Liege. 2000;55:226–32.
194. Smith GCS, Pell JC. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ. 2003;327. doi: 10.1136/bmj.327.7429.1459.
195. Haute Autorité de Santé: Élaboration de Recommandations de Bonne Pratique. Méthode. “Recommandations pour la pratique clinique”. 2010. Annexe 3, p. 19.
196. Haynes B, Haines A. Getting research fi ndings into practice, Barriers and bridges to evidence based clinical practice. BMJ. 1998;317:273–6.
197. Haynes RB. Loose connections between peer-reviewed clinical journals and clinical practice. Ann Intern Med. 1990;113:724–8.
198. Cochrane Reviews. The Cochrane Collaboration. http://www2.cochrane.org/reviews/.Accessed 20 Apr 2014.
199. Westerneck TB, Pak MH. Using clinical practice guidelines to improve patient care. Wis Med J. 2005;104:30–3.
200. Straus SE, Richardson WS, Glasziou P, Haynes RB. Evidence-Based Medicine: how to teach and practice EBM. Elsevier; 2005. p. 208.
201. Kamhi AG. Balancing certainty and uncertainty in clinical practice. Lang Speech Hear Serv Sch. 2011;42:59–64.
202. Bayes T, Price M. An essay towards solving a problem in the doctrine of chances. Philos Trans R Soc Lond. 1763;53:370–418.
203. Mayer D. Essential Evidence-Based Medicine. New York: Cambridge University Press; 2004. p. 249.
204. Straus SE, Richardson WS, Glasziou P, Haynes RB. Evidence-Based Medicine: how to teach and practice EBM. Elsevier; 2005. p. 156.
205. Sox HC, Blatt MA, Higgins MC, Marton KI. Medical decision making. Philadelphia: American College of Physicians; 2007. p. 169–200.
206. Kuhn TS. The structure of scientifi c revolutions. Chicago: University of Chicago Press; 1962.
207. Howick J. The philosophy of Evidence-Based Medicine. Oxford: Wiley-Blackwell; 2011. p. 10.
208. Feinstein AR, Horwitz RL. Problems in the “evidence” of “Evidence-based Medicine”. Am J Med. 1997;103:529–35.
209. Ellis J, Mulligan I, Rowe J, Sackett DL. Inpatient general medicine is evidence based. Lancet. 1995;346:407–9.
210. Gill P, Dowell AC, Neal RD, Smith N, Heywood P, Wilson AE. Evidence based general practice: a retrospective study of interventions in one training practice. BMJ. 1996;312:8819–21.
211. Kulkarni A. The challenges of Evidence-Based Medicine: a philosophical perspective. Med Health Care Philos. 2005;8:255–60.
212. The Cardiac Arrhytmia Suppression Trial (CAST) Investigators. Preliminary Report: effect of encainamide and fl ecainide on mortality in a randomized trial of arrhytmia suppression after myocardial infarction. N Engl J Med. 1989;321:406–12.
213. Bursztajn AJ, Feinbloom RI, Hamon RM, Brodsky A. Medical choices, medical chances: how patients, families and physicians can cope with uncertainty. New York: iUniverse; 1990.
214. Freeman AC, Sweeney K. Why general practitioners do not implement evidence: qualitative study. BMJ. 2001;323:1100–2.
215. Bachimont J, Cogneau J, Letourmy A. Pourquoi les médecins généralistes n’observent-ils pas les recommandations de bonnes pratiques cliniques ? L’exemple du diabète de type 2. Sciences Sociales et Santé. 2006;24:75–103.
216. Cogneau J, Lehr-Drylewicz AM, Bachimont J, Letourmy A. Ecarts entre le référentiel et la pratique dans le diabète de type 2. Les préjugés des médecins et des patients sont un obstacle à une éducation effi cace des patients. Presse Med. 2007;36:764–70.
217. Dijkstra R, Braspenning J, Uiters E, van Ballegooie E, Grol RT. Perceived barriers to the implementation of diabetes guidelines in hospitals in the Netherlands. Neth J Med. 2000; 56:80–5.
218. Price D, Thomas M. Breaking new ground: challenging existing asthma guidelines. BMC Pulm Med. 2006;6 Suppl 1:S6. doi: 10.1186/1471-2466-6-S1-S6.
219. Hobbs FD, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract. 2002;19:596–604.
220. Carlsen B, Glenton C, Pope C. Thou shalt versu thou shalt not: a meta-synthesis of GPs’ attitudes to clinical practice guidelines. Br J Gen Pract. 2007;57:971–8.
221. Lugtenberg M, Burgers JS, Besters CF, Han D, Westert GP. Perceived barriers to guideline adherence: a survey among general practitioners. BMC Fam Pract. 2011;12:98.
222. Heselmans A, Donceel P, Aertgeerts B, Van de Velde S, Ramaekers D. The attitude of begian social insurance physicians towards evidence-based practice and clinical practice guidelines. BMC Fam Pract. 2009;10:64. doi: 10.1186/1471-2296-10-64.
223. Straus SE, McAlister FA. Evidence-vased medicine: a commentary on common criticisms. CMAJ. 2000;163:837–41.
224. Straus SE, Sackett DL. Applying evidence to the individual patient. Ann Oncol. 1999;10: 29–32.
225. Parker M. False dichotomies: EBM, clinical freedom, and the art of medicine. J Med Ethics Med Humanit. 2005;31:23–30.
226. Tinetti ME, Bogardus ST, Agostini JV. Potential pitfalls of disease-specifi c guidelines for patients with multiple conditions. N Engl J Med. 2004;351:2870–4.
227. Pedone C, Lapane KL. Generalizability of guidelines and physicians’ adherence. Case study on the Sixth Joint National Committe’s guidelines on hypertension. BMC Public Health. 2003;3:24. doi: 10.1186/1471-2458-3-24.
228. Summerskill W. Evidence-based practice and the individual. Lancet. 2005;365:13–4.
229. Tonelli MR. Integrating clinical research into clinical decision making. Ann Ist Super Sanita. 2011;47:26–30.
230. Campbell NC, Murchie P. Treating hypertension with guidelines in general practice. Patients decide how low they go, no targets. BMJ. 2004;329:523–4.
231. Justice L. Evidence-based terminology. Am J Speech Lang Pathol. 2008;17:324–5.
232. McColl A, Smith H, White P, Field J. General practitioners’ perceptions of the route to evidence based medicine: a questionnaire survey. BMJ. 1998;316:361–5.
233. Bobrie G, Durieux P, Postel-Vinay N, Plouin PF. De l’observation clinique à l’évaluation des pratiques: les recommandations pour la prise en charge de l’hypertension artérielle. Néphrologie et Thérapeutique. 2009;5:S240–5.
234. Georg G, Colombet I, Durieux P, Ménard J, Meneton P. A comparative analysis of four clinical guidelines for hypertension management. J Hum Hypertens. 2008;22:829–37.
235. Stone TT, Schweikart SB, Mantese A, Sonnad SS. Guideline attribute and implementation preferences among physicians in multiple health systems. Qual Manag Health Care. 2005;14:177–87.
236. Kang MK, Kim BK, Kim TW, Kang HR, Park HW, Chang YS, Kim SS, Min KU, Kim YY, Cho SH. Physicians’ preferences for asthma guidelines implementation. Allergy Asthm Immunol Res. 2010;2:247–53.
237. Michie S, Johnston M. Changing clinical behaviour by making guidelines specifi c. BMJ. 2004;328:343–5.
238. Schön DA. The refl ective practitioner. How professionals think in action. New York: Basic Books; 1983.
239. Ely JW, Osheroff JA, Maviglia SM, Rosenbaum MME. Patient-care questions that physicians are unable to answer. J Am Med Inform Assoc. 2007;14:1407–14.
240. Horn SD, Gassaway J, Pentz L, James R. Practice-based evidence for clinical practice improvement: an alternative study design for Evidence-Based Medicine. In: Hovenga EJS et al., editors. Health informatics. IOS Press; 2010. p. 446–60.
241. Woolf SH. Do clinical practice guidelines defi ne good medical care? The need for good science and the disclosure of uncertainty when defi ning best practices. Chest. 1998;113:166S–71.
242. Medow MA, Lucey CR. A qualitative approach to Bayes’ theorem. Evid Based Med. 2011. doi: 10.1136/ebm-2011-0007.
243. Lewis JP, Tully MP. The discomfort of an evidence-based prescribing decision. J Eval Clin Pract. 2009;15:1152–8.
244. Reid MC, Lane DA, Feinstein AR. Academic calculations versus clinical judgments: practicing physicians’ use of quantitative measures of test accuracy. Am J Med. 1998;104:374–80.
245. Gabbay J, le May A. Evidence based guidelines or collectively constructed “mindlines”? Ethnographic study of knowledge management in primary care. BMJ. 2004;329:1013–7.
246. Gill PS, Freemantle N, Bero L, Haaijer-Ruskamp F, Markela M, Barjesteh KP. GPs’ prescribing behaviour may be affected by drug promotion. BMJ. 1996;313:367.
247. Lexchin J. Interactions between physicians and the pharmaceutical industry: what does the literature say? Can Med Assoc J. 1993;149:1402–22.
248. Armstrong D, Reyburn H, Jones R. A study of general practitioner's reasons for changing their prescribing behaviour. BMJ. 1996;312:949–52.
249. Zipkin DA, Steinman MA. Interactions between pharmaceutical representatives and doctors in training. A thematic review. J Gen Intern Med. 2005;20:777–86.
250. Chen MM, Landefeld CS. Physicians’ behavior and their interactions with drug companies. JAMA. 1994;271:684–9.
251. Loi n°2011–2012 du 29 Décembre 2011 relative au renforcement de la sécurité sanitaire du médicament et des produits de santé, JORF n° 0302 du 30 décembre 2011. p. 22667.
252. Morris AH. The importance of protocol-directed patient management for research on lungprotective ventilation. In: Dreyfuss D, Saumon G, Hubamyr R, editors. Ventilator-induced lung injury. New York: Taylor and Francis Group; 2006. p. 537–610.
253. Veazie PJ, Johnson PE, O’Connor PJ. Is there a downside to customizing care? Implications of general and patient-specifi c treatment strategies. J Eval Clin Pract. 2009;15:1171–6.
254. Inzuchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35:1364–79.
255. Inzuchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;55:1577–96.
256. Reach G. Clinical inertia, uncertainty and individualized guidelines. Diabetes Metab. 2014. doi: 10.1016/j.diabet.2013.12.009.
257. Balla JI, Elstein AS, Christensen C. Obstacles to acceptance of clinical decision analysis. BMJ. 1989;298:579–82.
258. Halimi S, Attali C. L’inertie thérapeutique dans le diabète de type 2: la comprendre sans la banaliser. Médecine des Maladies Métaboliques. 2011;5 Suppl 2:S62–8.
259. Reach G. The mental mechanisms of patient adherence to long term therapies, mind and care, Foreword by Pascal Engel, “Philosophy and Medicine” series, Springer, forthcoming
260. Davidson D. Actions, reasons and causes, Journal of Philosophy, 1963, repris comme Essai 1 de Action et événements, traduction et préface de P. Engel, P.U.F., Collection Épiméthée, 1993.
261. Reach G. The mental mechanisms of patient adherence to long term therapies, mind and care, Foreword by Pascal Engel, “Philosophy and Medicine” series, Springer, forthcoming.
262. Searle J. L’Intentionalité, Editions de Minuit, 1985.
263. Livet P. Émotions et rationalité morale, P.U.F., Collection Sociologies, 2002.
264. Reach G. Patient nonadherence and healthcare-provider inertia are clinical myopia. Diabetes Metab. 2008;34:382–5.
265. Gabbay J, le May A. Evidence based guidelines or collectively constructed “mindlines”? Ethnographic study of knowledge management in primary care. BMJ. 2004;329:1013–7.
266. Kahneman D, Tversky A. Choices, values and frames. In: Kahneman D, Tversky A, editors. Choices, values and frames. Cambridge, UK: Cambridge University Press; 2000. p. 1–16.
267. Gilovich T, Griffi n D. Introduction –Heuristics and biases: then and now. In: Gilovich T, Griffi n D, Kahnneman D, editors. Heuristics and biases. The psychology of intuitive judgment. New York/Cambridge, UK: Cambridge University Press; 2002. p. 1–2.
268. Tversky A, Kahneman D. Judgment under uncertainty: heuristics and biases. Science. 1974;185:1124–31.
269. Croskerry P. The cognitive imperative: thinking about how we think. Acad Emerg Med. 2000;7:1223–31.
270. Payne VL, Crowley RS. Assessing use of cognitive heuristic representativeness in clinical reasoning. In: AMIA 2008 symposium proceedings, AMIA Symposium, American Medical Informatics Association. 2008. p. 571–5.
271. Kai J, Beavan J, Faull C, Lynne D, Gill P, Beighton A. Professional uncertainty and disempowerment responding to ethnic diversity in health care: a qualitative study. PLoS Med. 2007;4:1766–75.
272. Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica. 1979;47:263–92.
273. McNeil BJ, Pauker SG, Sox Jr HC, Tversky A. On the elicitation of preferences for alternative therapies. N Engl J Med. 1982;306:1259–62.
274. Wegwarth O, Gaissmaier W, Gigerenzer G. Smart strategies for doctors and doctors-intraining: heuristics in medicine. Med Educ. 2009;43:721–8.
275. Dawson NV. Physician judgment in clinical settings: methodological infl uences and cognitive performances. Clin Chem. 1993;39:1468–80.
276. Bornstein BH, Emler AC. Rationality in medical decision making: a review of the literature on doctors’ decision-making biases. J Eval Clin Pract. 2001;7:97–107.
277. Klein JG. Five pitfalls in decisions about diagnosis and prescribing. BMJ. 2005;330:781–3.
278. Elstein AS, Schwarz A. Clinical problem solving and diagnostic decision making: selective review of the cognitive literature. BMJ. 2002;324:729–32.
279. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338:1516–20.
280. Cavazos JM, Naik AD, Woofter A, Abraham S. Barriers to physician adherence to nonsteroidal anti-infl ammatory drug guidelines: a qualitative study. Aliment Pharmacol Ther. 2008;28:789–98.
281. Miles RW. Fallacious reasoning and complexity as route causes of clinical inertia. J Am Med Dir Assoc. 2007;8:349–54.
282. Miles RW. Cognitive bias and planning error: nullifi cation of EBM in the nursing home. J Am Med Dir Assoc. 2010;11:194–203.
283. Masquelet AC. Le Raisonnement médical. P.U.F. “Que sais-je?”, Paris, 2006.
284. Croskerry P. A universal model of diagnostic reasoning. Acad Med. 2009;84:1022–8.
285. Croskerry P, Nimmo GR. Better clinical decision making and reducing diagnostic error. J R Coll Physicians Edinb. 2011;41:155–62.
286. Croskerry P. From mindless to mindful practice–cognitive bias and clinical decision making. N Engl J Med. 2013;368:2445–8.
287. Croskerry P, Singhal G, Mamede S. Cognitive debiasing 1: origins of bias and theory of debiasing. BMJ Qual Saf. 2013;22 Suppl 2:ii58–64.
288. Tappolet C. Emotions and the intelligibility of akratic actions. In: Stroud S, Tappolet C, editors. Weakness of will and practical irrationality. Clarendon Press: Oxford; 2003. p. 97–120.
289. Summerskill WSM, Pope C. I saw the panic rise in her eyes, and evidence-based medicine went out of the door. An exploratory qualitative study of the barriers to secondary prevention in the management of coronary heart disease. Fam Pract. 2002;19:605–10.
290. de Souza R. The rationality of emotion. Cambridge: MIT Press; 1987. p. 195–8.
291. Berthoz A. La Décision, Editions Odile Jacob, 2002.
292. Damasio AR. Descartes’ error. Emotions, reason and the human brain. New York: G. P. Putnam’s Sons; 1994.
293. Croskerry P, Abbass A, Wu AW. Emotional infl uences in patient safety. J Patient Saf. 2010;6:199–205.
294. Stolper E, Van de Wiel M, Van Royen P, Van Bokhoven M, Van der Weijden T, Dinant GJ. Gut feelings as a third track in general practitioners’ diagnostic reasoning. J Gen Intern Med. 2011;26:197–203.
295. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med. 2001;135:825–34.
296. Slovic P, Finucane M, Peters E, MacGregor DG. The affect heuristic. In: Gilovich T, Griffi n D, Kahneman D, editors. Heuristics and biases: the psychology of intuitive judgment. Cambridge, MA: Cambridge University Press; 2002. p. 397–420.
297. Loewenstein GF, Weber EU, Hsee CK, Welch N. Risk as feelings. Psychol Bull. 2001;127:267–86.
298. Oum R, Lieberman D. Emotion is cognition: an information-processing view of the mind. In: Vohs KD, Baumeister RF, Loewenstein G, editors. Do emotions help or hurt decision making. New York: Russell Sage; 2007. p. 117–32.
299. Baumeister RF, Vohs KD, DeWall CN, Zhang L. How emotion shapes behavior: feedback, anticipation, and refl exion, rather than direct causation. PSPR. 2007;11:167–203.
300. Coricelli G, Dolan RJ, Sirigu A. Brain, emotion and decision making: the paradigmatic example of regret. Trends Cogn Sci. 2007;11:258–65.
301. Kahneman D, Tversky A. The simulation heuristic. In: Kahneman D, Slovic P, Tversky A, editors. Judgment under uncertainty. New York/Cambridge, UK: Cambridge University Press; 1982. p. 201–8.
302. Tykocinski OE, Pittman TS. Product aversion following a missed opportunity: price contrast or avoidance of anticipated regret? Basic Appl Soc Psychol. 2001;23:149–56.
303. Feinstein AR. The ‘chagrin factor’ and qualitative decision analysis. Arch Intern Med. 1985;145:1257–9.
304. Baumeister RF, Bratslavsky E, Finkenauer C, Vohs KD. Bad is stronger than good. Rev Gen Psychol. 2001;5:323–70.
305. Choudhry NK, Anderson GM, Laupacis A, Ross-Degnan D, Normand SLT, Soumerai SB. Impact of adverse events on prescribing warfarin in patients with atrial fi brillation: matched pair analysis. BMJ. 2006;332:141–5. doi: 10.1136/bmj.38698.709572.55.
306. Higgins ET. Beyond pleasure and pain. Am Psychol. 1997;52:1280–300.
307. Veazie PJ, Qian F. A role for regulatory focus in explaining and combating clinical inertia. J Eval Clin Pract. 2011;17:1147–52.
308. Higgins ET, Shah J, Friedman R. Emotional responses to goal attainment: strength of regulatory focus as moderator. J Pers Soc Psychol. 1997;72:515–25.
309. Bagozzi RP, Baumgartner H, Pieters R. Goal-directed emotions. Cogn Emotion. 1998;12:1–26.
310. Reach G. Une Théorie du soin, Souci et amour face à la maladie. Préface de Bernard Baertschi, Les Belles Lettres “Médecine et Sciences Humaines”, Paris, 2010.
311. Rogers C. Psychothérapie et relations humaines, vol. 1. Louvain: Editions Universitaires; 1962. p. 197.
312. Wispé L. The distinction between sympathy and empathy: to call forth a concept, a word is needed. J Pers Soc Psychol. 1996;50:314–21.
313. Kalis A, Mojzisch A, Schweizer TS, Kaiser S. Weakness of will, akrasia, and the neuropsychiatry of decision making: an interdisciplinary perspective. Cogn Affect Behav Neurosci. 2008;8:402–17.
314. Anderson CJ. The psychology of doing nothing: forms of decision avoidance result from reason and emotion. Psychol Bull. 2003;129:139–67.
315. Parchman ML, Pugh JA, Romero RL, Bowers KW. Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. Ann Fam Med. 2007;5:196–201.
316. Jandrain BJ, Ernest PH, Radermcker RP, Scheen AJ. Stratégies pour éviter l’inertie et la nonobservance dans les essais cliniques. Rev Med Liege. 2010;65:246–9.
317. Schiff GD, Galanter WL, Duhig J, Lodolce AE, Koronkowski MJ, Lambert BL. Principles of conservative prescribing. Arch Intern Med. 2011;17:1433–40.
318. Wegwarth O, Gaissmaier W, Gigerenzer G. Smart strategies for doctors and doctors-intraining: heuristics in medicine. Med Educ. 2009;43:721–8.
319. Reach G. Patient nonadherence and healthcare-provider inertia are clinical myopia. Diabetes Metab. 2008;34:382–5.
320. Reach G. Non-observance et inertie clinique: deux mises en défaut de la relation de soin. In: Manuel de Médecine, Santé et Sciences Humaines, Collège des Enseignants de Sciences Humaines et Sociales en Médecine et Santé. Paris: Les Belles Lettres; 2011, p 284–92.
321. Sammer CE, Lykens K, Singh KP. Physician characteristics and the reported effect of evidence- based practice guidelines. Health Serv Res. 2008;43:569–81.
322. Lazaro P, Murga N, Aguilar D, Hernandez-Presa MA. Therapeutic Inertia in the outpatient management of dyslipidemia in patients with ischemic heart disease. The Inertia Study, Rev Esp Cardiol. 2010;63:1428–37.
323. Forsetlund L, Bjorndal A, Rashidian A, Jamtvedt G, O’Brien MA, Wolf F, Davis D, Odgaard- Jensen J, Oxman AD. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2009;(2):CD003030.
324. Mazmanian PE, Davis DA, Galbraith R. Continuing Medical Education effect on clinical outcomes. Chest. 2009;135:49S–55.
325. Cook CB, Wilson RD, Hovan MJ, Hull BP, Gray RJ, Apsey HA. Development of computerbased training to enhance resident physician management of inpatient diabetes. J Diabetes Sci Technol. 2009;3:1377–87.
326. Sperl-Hillen JM, O’Connor PJ, Rush WA, Johnson PE, Gilmer T, Biltz G, Asche SE, Ekstrom HL. Simulated physician learning program improves glucose control in adults with diabetes. Diabetes Care. 2010;33:1727–33.
327. Carpenter CR, Sherbino J. How does an “opinion leader” change my practice ? CJEM. 2010;12:431–4.
328. Flodgren G, Parmelli E, Doumit G, Gattellari M, O’Brien MA, Grimshaw J, Eccles MP. Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2011;(8):CD000125.
329. Jamtvedt G, Young JM, Kristoffersen DT, Thomson O’Brien MA, Oxman AD. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2006;(2). doi: 10.1002/14651858.CD000259.
330. Ziemer DC, Doyle JP, Barnes CS, Branch Jr WT, Cook CB, El-Kebbi IM, Gallina DL, Kolm P, Rhee MK, Phillips LS. An intervention to overcome clinical inertia and improve diabetes mellitus control in a primary care setting: Improving Primary Care of African Americans with Diabetes (IPCAAD) 8. Arch Intern Med. 2006;166:507–13.
331. O’Connor PJ, Sperl-Hillen J, Johnson PE, Rush WA, Crain AL. Customized feedback to patients and providers failed to improve safety or quality of diabetes care: a randomized trial. Diabetes Care. 2009;32:1158–63.
332. Roumie CL, Elasy TA, Greevy R, Griffi n MR, Liu X, Stone WJ, Wallston KA, Dittus RS, Alvarez V, Cobb J, Speroff T. Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial. Ann Intern Med. 2006;145:165–75.
333. Roumie CL, Elasy TA, Wallston KA, Pratt S, Greevy RA, Liu X, Alvarez V, Dittus RS, Speroff T. Clinical inertia: a common barrier to changing provider prescribing behavior. Jt Comm J Qual Patient Saf. 2007;33:277–85.
334. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud P-AC, Rubin HR. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–67.
335. Moser M. Physician or clinical inertia: what it is? Is it realy a problem? And what can be done about it? J Clin Hypertens. 2009;11:1–4.
336. Scheen AJ, Bourguignon JP, Guillaume M, et les membres du Programme EUDORA. L’Éducation Thérapeutique: une solution pour vaincre l’inertie clinique et le défaut d’observance. Rev Med Liège. 2010;65:250–5.
337. Lüders S, Schrader J, Schmieder RE, Smolka W, Wegscheider K, Bestehorn K. Improvement of hypertension management by structured physician education and feedback system: cluster randomized trial. Eur J Cardiovasc Prev Rehabil. 2010;17:271–9.
338. Boaz A, Baeza J, Fraser A. Effective implementation of research into practice: an overview of systematic reviews of the health literature. BMC Research Notes. 2011;4:212. http://www.biomedcentral.com/1756-0500/4/212. Accessed 21 Apr 2014.
339. Goderis G, Borgermans L, Grol R, Van Den Broeke C, Boland B, Verbeke G, Carbonez A, Mathieu C, Heyrman J. Start improving the quality of care for people with type 2 diabetes through a general practice support program: a cluster randomized trial. Diabetes Res Clin Pract. 2010;88:56–64.
340. Shah BR, Bhattacharyya O, Yu CH, Mamdani MM, Parsons JA, Straus SE, Zwarenstein M. Effect of an educational toolkit on quality of care: a pragmatic cluster randomized trial. PLoS Med. 2014;11(2):e1001588. doi: 10.1371/journal.pmed.1001588.
341. Bailey CJ, Kodack M. Patient adherence to medication requirements for therapy of type 2 diabetes. Int J Clin Pract. 2011;65:314–22.
342. Basile J, Neutel J. Overcoming clinical inertia to achieve blood pressure goals: the role of fi xed-dose combination therapy. Ther Adv Cardiovasc Dis. 2010;4:119–27.
343. Scheen AJ, Lefèbvre PJ, Kulbertus H. Prévention cardio-vasculaire: la “polypill”, une solution pour vaincre l’inertie clinique et le manque d’observance? Rev Med Liege. 2010;65:267–72.
344. Chrysant SG. Single-pill triple-combination therapy: an alternative to multiple-drug treatment of hypertension. Postgrad Med. 2011;123:21–31.
345. Nicolucci A, Rossi MC. Incretin-based therapies: a new potential treatment approach to overcome clinical inertia in type 2 diabetes. Acta Biomed. 2008;79:184–91.
346. Triplitt C. Improving treatment success rates for type 2 diabetes: recommendations for a changing environment. Am J Manag Care. 2010;16:S195–200.
347. Morris AH, Orme Jr J, Truwit JD, Steingrub J, Grissom C, Lee KH, Li GL, Thompson BT, Brower R, Tidswell M, Bernard GR, Sorenson D, Sward K, Zheng H, Schoenfeld D, Warner H. A replicable method for blood glucose control in critically Ill patients. Crit Care Med. 2008;36:1787–95.
348. Sward K, Orme Jr J, Sorenson D, Baumann L, Morris AH, Reengineering Critical Care Clinical Research Investigators. Reasons for declining computerized insulin protocol recommendations: application of a framework. J Biomed Inform. 2008;41:488–97.
349. Miller CD, Ziemer DC, Kolm P, El-Kebbi IM, Cook CB, Gallina DL, Doyle JP, Barnes CS, Phillips LS. Use of a glucose algorithm to direct diabetes therapy improves A1C outcomes and defi nes an approach to assess provider behavior. Diabetes Educ. 2006;32:533–45.
350. Gandara E, Moniz TT, Dolan ML, Melia C, Dudley J, Smith A, Kachalia A. Improving adherence to treatment guidelines: a blueprint. Crit Pathw Cardiol. 2009;8:139–45.
351. Kiberd J, Panek R, Kiberd B. Strategies to reduce clinical inertia in hypertensive kidney transplant recipients. BMC Nephrol. 2007;8:10. doi: 10.1186/1471-2369-8-10.
352. Hyman DJ, Pavlik VN, Greisinger AJ, Chan W, Bayona J, Mansyur C, Simms V, Pool J. Effect of a physician uncertainty reduction intervention on blood pressure in uncontrolled hypertensives-A Cluster Randomized Trial. J Gen Intern Med. 2012;27:413–9. PMID: 22033742.
353. Varroud-Vial M. Improving diabetes management with electronic medical records. Diabetes Metab. 2011;37:S48–52.
354. Benhamou PY. Improving diabetes management with electronic health records and patients’ health records. Diabetes Metab. 2011;37:S53–6.
355. Cebul RD, Love TE, Jain AK, Hebert CJ. Electronic health records and quality of diabetes care. N Engl J Med. 2011;365:825–33.
356. Zhou YY, Kanter MH, Wang JJ, Garrido T. Improved quality at Kaiser Permanente through e-mail between physicians and patients. Health Aff. 2010;29:1370–5.
357. Perlin JB, Pogach LM. Improving the outcomes of metabolic conditions: managing momentum to overcome clinical inertia. Ann Int Med. 2006;144:525–7.
358. Krein SL, Hofer TP, Kerr EA, Hayward RA. Whom should we profi le? Examining diabetes care practice variation among primary care providers, provider groups, and health care facilities. Health Serv Res. 2002;37:1159–80.
359. Ward MM, Yankey JW, Vaughn TE, BootsMiller BJ, Flach SD, Welke KF, Pendergast JF, Perlin J, Doebbeling BN. Physician process and patient outcome measures for diabetes care: relationships to organizational characteristics. Med Care. 2004;42:840–50.
360. Sophia, le service d’accompagnement de l’Assurance Maladie pour les personnes atteintes de maladie chronique. http://www.ameli.fr/fileadmin/user_upload/documents/DP_sophia_220108.pdf. Accessed 21 Apr 2014.
361. Reach G. Le malade, son médecin, et le “disease manager”. Médecine des Maladies Métaboliques. 2007;1:83–7.
362. Varroud-Vial M. Le parcours de soin: une solution ou une contrainte supplémentaire? Médecine des Maladies Métaboliques. 2011;5 Suppl 2:S81–5.
363. Avignon A, Attali C, Sultan A, Ferrat E, Le Breton J. Clinical inertia: viewpoints of general practitioners and diabetologists. Diabetes Metab. 2012;38 Suppl 3:S53–8.
364. Anderson CJ. The psychology of doing nothing: forms of decision avoidance result from reason and emotion. Psychol Bull. 2003;129:139–67.
365. Franc S, Daoudi A, Mounier S, Boucherie B, Laroye H, Peschard C, Dardari D, Juy O, Requeda E, Canipel L, Charpentier G. Telemedicine: what more is needed for its integration in everyday life? Diabet Med. 2011;37:S71–7.
366. Chabouis A, Berdugo M, Meas T, Erginay A, Laloi-Michelin M, Jouis V, Guillausseau PJ, M’bemba J, Chaine G, Slama G, Cohen R, Reach G, Marre M, Chanson P, Vicaut E, Massin P. Benefi ts of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in fi ve reference hospital centres. Diabetes Metab. 2009;35:228–32.
367. Charpentier G, Benhamou PY, Dardari D, Clergeot A, Franc S, Schaepelynck-Belicar P, Catargi B, Melki V, Chaillous L, Farret A, Bosson JL, Penfornis A, TeleDiab Study Group. The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, openlabel, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care. 2011;34:533–9.
368. Reach G. The mental mechanisms of patient adherence to long term therapies, mind and care, Foreword by Pascal Engel, “Philosophy and Medicine” series, Springer, forthcoming.
369. Rosenthal MB, Frank RG, Zhonghe L, Epstein AM. Early experience with pay-forperformance: from concept to practice. JAMA. 2005;294:1788–93.
370. Lindenauer PK, Remus D, Roman S, Rothberg MB, Benjamin EM, Ma A, Bratzler DW. Public reporting and pay for performance in hospital quality improvement. N Engl J Med. 2007;356:486–96.
371. Lynagh MC, Sanson-Fisher RW, Bonevski B. What’s good for the goose is good for the gander. Guiding principles for the use of fi nancial incentives in health behavior change. Int J Behav Med. 2011. doi: 10.1007/s12529-011-9202-5.
372. Glickman SW, Peterson ED. Innovative health reform models: pay-for-performance initiatives. Am J Manag Care. 2009;15:S300–5.
373. Elridge C, Palmer N. Performance-based payment: some refl ections on the discourse, evidence and unanswered questions. Health Policy Plan. 2009;24:160–6.
374. Aron D, Pogach L. Specialists vs generalists in the era of pay for performance: “a plague o’both your houses !”. Qual Saf Health Care. 2007;16:3–5.
375. Fink KS. Value-driven health care: proceed with caution. J Am Board Fam Med. 2008;21:458–60.
376. Baumann MH, Dellert E. Performance measures and pay for performance. Chest. 2006;129:188–91.
377. Van Herck P, De Smedt D, Annemans L, Remmen R, Rosenthal MB, Sermeus W. Systematic review: effects, design choices, and context of pay-for-performance in health care. BMC Health Serv Res. 2010;10:247.
378. De Bruin S, Baan CA, Struijs J. Pay-for performance in disease management: a systematic review of the literature. BMC Health Serv Res. 2011;11:272.
379. Scott A, Sivey P, Ait Ouakrim D, Willenberg L, Naccarella L, Furler J, Young D. The effect of fi nancial incentives on the quality of health care provided by primary care physicians. Cochrane Database Syst Rev. 2011;(9):CD008451.
380. Houle SK, McAlister FA, Jackevicius CA, Chuck AW, Tsuyuki RT. Does performance-based remuneration for individual health care practitioners affect patient care?: a systematic review. Ann Intern Med. 2012;157:889–99.
381. Huang J, Yin S, Lin Y, Jiang Q, He Y, Du L. Impact of pay-for-performance on management of diabetes: a systematic review. J Evid Based Med. 2013;6(3):173–84. doi: 10.1111/jebm.12052.
382. Le contrat d’amélioration des pratiques individuelles (CAPI). http://www.securite-sociale.fr/IMG/pdf/fiche_eclairage_maladie_capi_sept_2011.pdf. Accessed 7 Sept 2014.
383. Le contrat d’amélioration des pratiques individuelles (CAPI). http://www.securite-sociale.fr/IMG/pdf/fi che_eclairage_maladie_capi_sept_2011.pdf. Accessed 21 Apr 2014.
384. Sutton E, Wilson H, Kaboli PJ, Carter BL. Why physicians do not prescribe thiazide diuretics. J Clin Hypertens (Greenwich). 2010;12:502–7.
385. Agarwal R, Bills JE, Hecht TJ, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension. 2011;57:29–38.
386. Grant RW, Wald JS, Schnipper JL, Gandhi TK, Poon EG, Orav EJ, Williams DH, Volk LA, Middleton B. Practice-linked online personal health records for type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med. 2008;168:1776–82.
387. Portnoy DB, Scott-Sheldon LAJ, Johnson BT, Carey M. Computer-delivered interventions for health promotion and behavioral risk reduction: a meta-analysis of 75 randomized controlled trials, 1988–2007. Prev Med. 2008;47:3–16.
388. Thiboutot J, Stuckey H, Binette A, Kephart D, Curry W, Falkner B, Sciamanna C. A webbased patient activation intervention to improve hypertension care: study design and baseline characteristics in the web hypertension study. Contemp Clin Trials. 2010;3:634–46.
389. Groupes de pairs, le plaisir de se former ensemble. http://www.sfmg.org/groupe_de_pairs/. Accessed 9 Apr 2011.
390. Fiscella K, Volpe E, Winters P, Brown M, Idris A, Harren T. A novel approach to quality improvement in a safety-net practice: concurrent peer review visits. J Natl Med Assoc. 2010;102:1231–6.
391. van Bruggen R, Gorter K, Stolk R, Klungel O, Rutten G. Clinical inertia in general practice: widespread and related to the outcome of diabetes care. Fam Pract. 2009;26:428–36.
392. Kennedy AG, MacLean CD. Clinical inertia: errors of omission in drug therapy. Am J Health Syst Pharm. 2004;61:401–4.
393. Kirwin JL, Cunningham RJ, Sequist TD. Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial. J Manag Care Pharm. 2010;16:104–13.
394. Carter BL, Bergus GR, Dawson JD, James PA, Bergus GR, Doucette WR, Chrischilles EA, Franciscus CL, Xu Y. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens. 2008;10:260–71.
395. Elster J. Ulysses unbound, rationality, precommitments and constraints. Cambridge: Cambridge University Press; 2000.
396. Gollwitzer PM, Schaal B. Metacognition in action: the importance of implementation intentions. Pers Soc Psychol Rev. 1998;2:124–36.
397. Holton R. How is strength of will possible? In: Stroud S, Tappolet C, editors. Weakness of will and practical irrationality. Oxford: Clarendon; 2003. p. 39–67.
398. Searle J. Intentionality: an essay in the philosophy of mind. Cambridge, UK: Cambridge University Press; 1983.
399. Reach G. Role of habit in adherence to medical treatment. Diabet Med. 2005;22:415–20.
400. Proust J. La Nature de la volonté. Paris: Gallimard; 2005.
401. Wise RA, Bozarth MA. A psychomotor stimkalnt theory of addiction. Psychol Rev. 1987;94:469–92.
402. Engel P. Préface à Paradoxes de l’irrationalité de Donald Davidson. Combas, L’Éclat; 1991.
403. Pears D. Motivated irrationality. South Bend: St Augustine’s Press; 1998. p. 1.
404. Croskerry P. The cognitive imperative: thinking about how we think. Acad Emerg Med. 2000;7:1223–31.
405. Epstein RM, Siegel DJ, Silberman J. Self-monitoring in clinical practice: a challenge for medical educators. J Contin Educ Health Prof. 2008;28:5–13.
406. Bradley CP. Commentary: can we avoid bias? BMJ. 2005;330:784.
407. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS. Clinical inertia. Ann Intern Med. 2001;135:825–34.
408. Wexler R, Elton T, Taylor CA, Pleister A, Feldman D. Physician reported perception in the treatment of high blood pressure does not correspond to practice. BMC Fam Pract. 2009;10:23.
409. Feinstein AR. The ‘chagrin factor’ and qualitative decision analysis. Arch Intern Med. 1985;145:1257–9.
410. Studdert DM, Mello MM, Sage WM, DesRoches CM, Peugh J, Zapert K, Brennan TA. Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. JAMA. 2005;293:2609–17.
411. Frankfurt HG. The importance of what we care about. Cambridge, UK: Cambridge University Press; 1988.
412. Darwall S. Welfare and rational care. In: Princeton monographs in philosophy. Princeton: Princeton University Press; 2002.
413. Elster J. Alchemies of the mind: rationality of emotions. Cambridge: Cambridge University Press; 1999. p. 241.
414. Carver CS, Scheier MF, Segerstrom SC. Optimism. Clin Psychol Rev. 2010;30:879–89.
415. Higgins ET. Beyond pleasure and pain. Am Psychol. 1997;52:1280–300.
416. Veazie PJ, Qian F. A role for regulatory focus in explaining and combating clinical inertia. J Eval Clin Pract. 2011;17:1147–52.
417. Zikmund-Fisher BJ, Hofer TP, Klamerus ML, Kerr EA. First things fi rst: diffi culty with current medications is associated with patient willingness to add new ones. Patient 2009;2:221–231.
418. Nguyen GC, LaVeist TA, Harris ML, Datta LW, Bayless TM, Brant SR. Patient trust-inphysician and race are predictors of adherence to medical management in infl ammatory bowel disease. Infl amm Bowel Dis. 2009;15:1233–9.
419. Thom DH, Campbell B. Patient-physician trust: an exploratory study. J Fam Pract. 1997;44: 169–76.
420. Thom DH. Stanford Trust Study Physicians, Physician behaviors that predict patient trust. J Fam Pract. 2001;50:323–8.
421. Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47:826–34.
422. Origgi G. Qu’est-ce que la confi ance Chemins philosophiques. Paris: Vrin; 2008. p. 7–8.
423. Hardin R. Trust and trustworthiness. New York: Russel Sage Foundation; 2004.
424. Spinoza. The Ethics, Part 4 of human bondage, Proposition LII, Proof and Corollary.
425. Spinoza. The Ethics, Part 3 on the origine and the nature of the emotions, Defi nitions XII and XIII.
426. Giugliano D, Esposito K. Clinical inertia as a clinical safeguard. JAMA. 2011;305:1591–2.
427. Gerstein HC, Miller ME, Byington RP, Goff Jr DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm Jr RH, Probstfield JL, Simons-Morton DG, Friedewald WT. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.
428. Mohan AV, Phillips LS. Clinical inertia and uncertainty in medicine. JAMA. 2011;306:383.
429. Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med. 2011;154:554–9.
430. Inzuchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;55:1577–96.
431. Inzuchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35:1364–79.
432. Stratégie médicamenteuse du contrôle glycémique du diabète de type 2. http://www.has-sante.fr/portail/jcms/c_1022476/fr/strategie-medicamenteuse-du-controle-glycemique-du-diabetede-type-2. Accessed 21 Apr 2014.
433. Esposito K, Ceriello A, Giugliano D. Does personalized diabetology overcome clinical uncertainty and therapeutic inertia in type 2 diabetes? Endocrine. 2013;44:343–5.
434. Persell SD, Dolan NC, Friesema EM, Thompson JA, Kaiser D, Baker DW. Frequency of inappropriate medical exceptions to quality measures. Ann Intern Med. 2010;152:225–31.
435. Crowley MJ, Smith VA, Olsen MK, Danus S, Oddone EZ, Bosworth HB, Powers BJ. Treatment intensifi cation in a hypertension telemanagement trial. Clinical inertia or good clinical judgment? Hypertension. 2011;58:552–8.
436. Schön DA. The refl ective practioner. How professionals think in action. New York: Basic Books; 1983.
437. Gabbay J, le May A. Evidence based guidelines or collectively constructed “mindlines”? Ethnographic study of knowledge management in primary care. BMJ. 2004;329:1013–7.
438. Reach G. Clinical inertia, uncertainty and individualized guidelines. Diabetes Metab. 2014. pii:S1262-3636(14)00003-2. doi: 10.1016/j.diabet.2013.12.009.
439. Oum R, Lieberman D. Emotion is cognition: an information-processing view of the mind. In: Vohs KD, Baumeister RF, Loewenstein G, editors. Do emotions help or hurt decision making. New York: Russell Sage Foundation; 2007. p. 117–32.
440. Anderson CJ. The psychology of doing nothing: forms of decision avoidance result from reason and emotion. Psychol Bull. 2003;129:139–67.
441. Saarni SI, Gylling HA. Evidence based medicine guidelines: a solution to rationing or politics disguised in science? J Med Ethics. 2004;30:171–5.
442. Baumeister RF, Vohs KD, DeWall CN, Zhang L. How emotion shapes behavior: feedback, anticipation, and refl exion, rather than direct causation. PSPR. 2007;11:167–203.
443. Groves JE. Taking care of the hateful patient. N Engl J Med. 1978;298:883–7.
444. Epstein RM, Siegel DJ, Silberman J. Self-monitoring in clinical practice: a challenge for medical educators. J Cont Educ Health Prof. 2008;28:5–13.
445. Cochrane AL. Effectiveness and effi ciency: random refl ections on health services. London: Nuffi eld Provincial Hospitals Trust; 1972. (réédition 1989, Royal Society of Medicine Press, London).
446. Miller LV, Goldstein J. More effi cient care of diabetic patients in a county-hospital setting. N Engl J Med. 1972;286:1388–91.
447. Beauchamp TF, Childress JL. Principles of biomedical ethics. New York: Oxford; 1979.
448. Schneewind JB. The invention of autonomy. Cambridge/New York: Cambridge University Press; 1998.
449. Parker M. False dichotomies: EBM, clinical freedom, and the art of medicine. J Med Ethics Med Humanit. 2005;31:23–30.
450. Arrêté du 2 août 2010 relatif aux compétences requises pour dispenser l’éducation thérapeutique du patient. Journal Offi ciel de la République Française n° 0178, 4 août 2010, texte 30.
451. Reach G. Une Éducation Thérapeutique sans posture n’est qu’une imposture. In: Éducation Thérapeutique, La Mise en Oeuvre, Synthèse Pratique Mise au point 2011–2012, Grimadi A, ed., Éditions Scientifi ques LC; 2011. p. 11–3.
452. Reach G. Patient autonomy in chronic care: solving a paradox. Patient Prefer Adherence. 2013;8:15–24.
453. Funnell MM, Anderson RM, Arnold MS, Barr PA, Donnelly M, Johnson PD, Taylor-Moon D, White NH. Empowerment: an idea whose time has come in diabetes education. Diabetes Educ. 1991;17:37–41.